Publications by authors named "Yuki Sinno"
Transl Lung Cancer Res
July 2023
Article Synopsis
- Crizotinib is an approved treatment for patients with non-small cell lung cancer (NSCLC) that has specific genetic rearrangements (C-ros and ALK).
- A study analyzed treatment outcomes and progression patterns of 26 C-ros-positive and 42 ALK-positive NSCLC patients who received crizotinib between 2011 and 2021, focusing on metastasis extent and response to the drug.
- Results showed that while the types and locations of metastases differed (with more extrathoracic metastases in C-ros-positive patients), the overall effectiveness of crizotinib, as measured by response rates and survival, was similar in both groups.
